KRTAP9-4

Across TCGA pan-cancer cohorts, KRTAP9-4 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of KRTAP9-4’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where KRTAP9-4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KRTAP9-4 is over-expressed in tumor.

LUSC are the cancer types where KRTAP9-4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KRTAP9-4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.029	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

KRTAP9-4–LUSC

Open the LUSC breakdown →